Back to Search
ELLIOT GOLDSTEIN, MD
MD
Internal Medicine Physician
NPI: 1619935665Individual
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
D0003581(MD)
Research & Publications (20)
Activity of a novel carbapenem, doripenem, against anaerobic pathogens.
PMID 19249176·Diagn Microbiol Infect Dis·2009
6-review
Infection after elective colorectal surgery: bacteriological analysis of failures in a randomized trial of cefotetan vs. ertapenem prophylaxis.
PMID 19226203·Surg Infect (Larchmt)·2009
2-rct
National hospital survey of anaerobic culture and susceptibility methods: III.
PMID 18291689·Anaerobe·2008
8-other
In vitro activities of doripenem and six comparator drugs against 423 aerobic and anaerobic bacterial isolates from infected diabetic foot wounds.
PMID 18070958·Antimicrob Agents Chemother·2008
8-other
In vitro activity of 11 antibiotics against 74 anaerobes isolated from pediatric intra-abdominal infections.
PMID 16701615·Anaerobe·2006
4-observational
In vitro activity of moxifloxacin against 923 anaerobes isolated from human intra-abdominal infections.
PMID 16377680·Antimicrob Agents Chemother·2006
8-other
Comparative in vitro activities of retapamulin (SB-275833) against 141 clinical isolates of Propionibacterium spp., including 117 P. acnes isolates.
PMID 16377717·Antimicrob Agents Chemother·2006
4-observational
In vitro activity of ceftobiprole against aerobic and anaerobic strains isolated from diabetic foot infections.
PMID 16982780·Antimicrob Agents Chemother·2006
8-other
Comparative in vitro susceptibilities of 396 unusual anaerobic strains to tigecycline and eight other antimicrobial agents.
PMID 16940056·Antimicrob Agents Chemother·2006
4-observational
In vitro activities of dalbavancin and 12 other agents against 329 aerobic and anaerobic gram-positive isolates recovered from diabetic foot infections.
PMID 16870792·Antimicrob Agents Chemother·2006
4-observational
Measuring hospital care from the patients' perspective: an overview of the CAHPS Hospital Survey development process.
PMID 16316434·Health Serv Res·2005
8-other
Comparative in vitro activities of XRP 2868, pristinamycin, quinupristin-dalfopristin, vancomycin, daptomycin, linezolid, clarithromycin, telithromycin, clindamycin, and ampicillin against anaerobic gram-positive species, actinomycetes, and lactobacilli.
PMID 15616322·Antimicrob Agents Chemother·2005
4-observational
Treatment of complicated community-acquired infections with ertapenem, the first Group 1 carbapenem. Introduction.
PMID 15228047·J Antimicrob Chemother·2004
8-other
In vitro activities of iodonium salts against oral and dental anaerobes.
PMID 15215147·Antimicrob Agents Chemother·2004
4-observational
In vitro activities of the new semisynthetic glycopeptide telavancin (TD-6424), vancomycin, daptomycin, linezolid, and four comparator agents against anaerobic gram-positive species and Corynebacterium spp.
PMID 15155214·Antimicrob Agents Chemother·2004
4-observational
Intra-abdominal infections: review of the bacteriology, antimicrobial susceptibility and the role of ertapenem in their therapy.
PMID 15150181·J Antimicrob Chemother·2004
7-preclinical
In vitro activities of telithromycin and 10 oral agents against aerobic and anaerobic pathogens isolated from antral puncture specimens from patients with sinusitis.
PMID 12760875·Antimicrob Agents Chemother·2003
8-other
In vitro activities of ABT-492, a new fluoroquinolone, against 155 aerobic and 171 anaerobic pathogens isolated from antral sinus puncture specimens from patients with sinusitis.
PMID 12937015·Antimicrob Agents Chemother·2003
8-other
Desulfovibrio desulfuricans bacteremia and review of human Desulfovibrio infections.
PMID 12791922·J Clin Microbiol·2003
5-case
In vitro activities of dalbavancin and nine comparator agents against anaerobic gram-positive species and corynebacteria.
PMID 12760876·Antimicrob Agents Chemother·2003
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 6000 EXECUTIVE BLVD, SUITE 300
ROCKVILLE, MD 20852 - Phone
- (301) 468-8999
Quick Facts
- NPI
- 1619935665
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile